Inspire Non Current Liabilities Total vs Total Current Liabilities Analysis
INSP Stock | USD 158.79 4.42 2.86% |
Inspire Medical financial indicator trend analysis is infinitely more than just investigating Inspire Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inspire Medical Systems is a good investment. Please check the relationship between Inspire Medical Non Current Liabilities Total and its Total Current Liabilities accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Non Current Liabilities Total vs Total Current Liabilities
Non Current Liabilities Total vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inspire Medical Systems Non Current Liabilities Total account and Total Current Liabilities. At this time, the significance of the direction appears to have weak relationship.
The correlation between Inspire Medical's Non Current Liabilities Total and Total Current Liabilities is 0.36. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Inspire Medical Systems, assuming nothing else is changed. The correlation between historical values of Inspire Medical's Non Current Liabilities Total and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Inspire Medical Systems are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Non Current Liabilities Total i.e., Inspire Medical's Non Current Liabilities Total and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.36 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Non Current Liabilities Total
Total Current Liabilities
Total Current Liabilities is an item on Inspire Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Inspire Medical Systems are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Inspire Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inspire Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. At this time, Inspire Medical's Selling General Administrative is relatively stable compared to the past year. As of 06/02/2024, Tax Provision is likely to grow to about 939.8 K, while Enterprise Value Over EBITDA is likely to drop (151.23).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 8K | 5.0M | 2.8M | 1.7M | Interest Income | 125K | 5.1M | 18.1M | 19.0M |
Inspire Medical fundamental ratios Correlations
Click cells to compare fundamentals
Inspire Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inspire Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 23.8M | 26.1M | 27.3M | 28.1M | 29.3M | 22.9M | |
Total Assets | 181.3M | 281.2M | 295.1M | 564.9M | 676.8M | 710.7M | |
Short Long Term Debt Total | 24.5M | 30.6M | 33.8M | 8.9M | 24.8M | 24.7M | |
Other Current Liab | 12.4M | 13.5M | 20.5M | 33.0M | 39.3M | 41.2M | |
Total Current Liabilities | 16.9M | 20.7M | 41.3M | 61.2M | 78.1M | 82.0M | |
Total Stockholder Equity | 139.8M | 229.7M | 229.0M | 496.0M | 572.5M | 601.1M | |
Net Tangible Assets | 139.8M | 229.7M | 229.0M | 496.0M | 570.4M | 598.9M | |
Property Plant And Equipment Net | 4.0M | 11.1M | 16.4M | 24.1M | 62.7M | 65.8M | |
Net Debt | 1.7M | (159.9M) | (180.7M) | (432.7M) | (160.7M) | (168.7M) | |
Retained Earnings | (180.2M) | (237.3M) | (279.4M) | (324.3M) | (345.4M) | (362.7M) | |
Accounts Payable | 4.5M | 7.2M | 11.7M | 26.8M | 38.8M | 40.8M | |
Cash | 22.9M | 190.5M | 214.5M | 441.6M | 185.5M | 160.6M | |
Non Current Assets Total | 10.6M | 11.3M | 26.5M | 34.8M | 83.1M | 87.2M | |
Non Currrent Assets Other | 802K | 381K | 204K | 215K | 11.3M | 11.8M | |
Long Term Debt | 24.9M | 24.5M | 24.7M | 15.8M | 18.2M | 21.8M | |
Cash And Short Term Investments | 149.5M | 234.4M | 214.5M | 451.4M | 460.4M | 236.7M | |
Net Receivables | 13.1M | 25.1M | 34.2M | 61.2M | 89.9M | 94.4M | |
Common Stock Total Equity | 23K | 24K | 27K | 29K | 33.4K | 22.6K | |
Short Term Investments | 90.9M | 126.6M | 43.8M | 9.8M | 274.8M | 288.6M | |
Long Term Debt Total | 24.9M | 24.5M | 24.7M | 15.8M | 18.2M | 21.8M | |
Liabilities And Stockholders Equity | 181.3M | 281.2M | 295.1M | 564.9M | 676.8M | 710.7M | |
Non Current Liabilities Total | 24.6M | 30.7M | 24.7M | 7.7M | 26.2M | 23.1M | |
Capital Surpluse | 319.9M | 467.0M | 508.5M | 820.3M | 943.4M | 990.6M | |
Inventory | 5.8M | 8.5M | 17.2M | 11.9M | 33.9M | 35.6M | |
Other Current Assets | 2.2M | 2.0M | 2.7M | 5.5M | 9.6M | 10.1M | |
Other Stockholder Equity | 319.9M | 467.0M | 508.5M | 820.3M | 917.1M | 478.1M | |
Total Liab | 41.4M | 51.4M | 66.0M | 68.9M | 104.3M | 56.6M | |
Property Plant And Equipment Gross | 4.0M | 11.1M | 16.4M | 24.1M | 69.9M | 73.4M | |
Total Current Assets | 170.6M | 269.9M | 268.5M | 530.0M | 593.7M | 623.4M | |
Accumulated Other Comprehensive Income | 102K | 29K | (55K) | (86K) | 800K | 840K | |
Common Stock | 23K | 24K | 27K | 29K | 30K | 23.9K | |
Property Plant Equipment | 4.0M | 5.3M | 16.4M | 17.2M | 19.8M | 20.8M | |
Net Invested Capital | 164.4M | 254.5M | 254.0M | 496.0M | 572.5M | 306.2M | |
Net Working Capital | 153.8M | 249.1M | 227.2M | 468.8M | 515.6M | 286.0M | |
Retained Earnings Total Equity | (180.2M) | (237.3M) | (279.4M) | (324.3M) | (291.8M) | (306.4M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Inspire Stock analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.682 | Earnings Share (0.52) | Revenue Per Share 22.454 | Quarterly Revenue Growth 0.282 | Return On Assets (0.04) |
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.